Cocchia N, Pasolini MP, Mancini R, Petrazzuoto O, Cristofaro I, Rosapane I, et al
Manufactured to WHO-GMP quality standards and marketed by Steris Healthcare Pvt
doi: 10.1128/mBio.02566-18
The average overall response rate to DBS was about 50%
Neurological damage from B12 deficiency is very slow to heal, often imperfectly healed and if not treated in time, may be permanent to at least some degree
Key Features Research Use Only (RUO) compound 50 mg per capsule for consistent research measurement 60 capsules per bottle Encapsulated format for ease of handling in laboratory settings Manufactured and packaged for research applications Product Specifications Compound Name: 5-Amino-1MQ Form: Capsules Dosage Strength: 50 mg per capsule Bottle Size: 60 capsules Grade: Research Use Only (RUO) Intended Use This product is intended solely for laboratory research and investigational purposes